News & information from UB, New York's flagship university
Release Date: September 2, 2008 This content is archived.
An article in The New York Times on clinical trials that have raised concerns about cancer risks and the use of the widely prescribed drugs Zetia and Vytorin quotes Peter Bradford, associate professor of pharmacology and toxicology. "One might envision that link. This is a very large question," he said.
John Della Contrada
Vice President for University Communications
521 Capen Hall
Buffalo, NY 14260
Tel: 716-645-4094 (mobile: 716-361-3006)
dellacon@buffalo.edu
Twitter: UBNewsSource